Literature DB >> 20550970

Skeletal phenotype of mandibuloacral dysplasia associated with mutations in ZMPSTE24.

Vicki J Cunningham1, Maria Rosaria D'Apice, Norma Licata, Giuseppe Novelli, Tim Cundy.   

Abstract

Mandibuloacral dysplasia (MAD) is a rare recessively inherited premature aging disease characterized by skeletal and metabolic anomalies. It is part of the spectrum of diseases called laminopathies and results from mutations in genes regulating the synthesis of the nuclear laminar protein, lamin A. Homozygous or compound heterozygous mutations in the LMNA gene, which encodes both the precursor protein prelamin A and lamin C, are the commonest cause of MAD type A. In a few cases of MAD type B, mutations have been identified in the ZMPSTE24 gene encoding a zinc metalloproteinase important in the post-translational modification of lamin A. Here we describe a new case of MAD resulting from compound heterozygote mutations in ZMPSTE24 (p.N256S/p.Y70fs). The patient had typical skeletal changes of MAD, but in addition a number of unusual skeletal features including neonatal tooth eruption, amorphous calcific deposits, submetaphyseal erosions, vertebral beaking, severe cortical osteoporosis and delayed fracture healing. Treatment with conventional doses of pamidronate improved estimated volumetric bone density in the spine but did not arrest cortical bone loss. We reviewed the literature on cases of MAD associated with proven LMNA and ZMPSTE24 mutations and found that the unusual features described above were all substantially more prevalent in patients with mutations in ZMPSTE24 than in those with LMNA mutations. We conclude that MAD associated with ZMPSTE24 mutations has a more severe phenotype than that associated with LMNA mutations--probably reflecting the greater retention of unprocessed farnesylated prelamin A in the nucleus, which is toxic to cells. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20550970     DOI: 10.1016/j.bone.2010.06.004

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation.

Authors:  Rabah Ben Yaou; Claire Navarro; Susana Quijano-Roy; Anne T Bertrand; Catherine Massart; Annachiara De Sandre-Giovannoli; Juan Cadiñanos; Kamel Mamchaoui; Gillian Butler-Browne; Brigitte Estournet; Pascale Richard; Annie Barois; Nicolas Lévy; Gisèle Bonne
Journal:  Eur J Hum Genet       Date:  2011-01-26       Impact factor: 4.246

2.  Expression of the Hutchinson-Gilford progeria mutation during osteoblast development results in loss of osteocytes, irregular mineralization, and poor biomechanical properties.

Authors:  Eva Schmidt; Ola Nilsson; Antti Koskela; Juha Tuukkanen; Claes Ohlsson; Björn Rozell; Maria Eriksson
Journal:  J Biol Chem       Date:  2012-08-14       Impact factor: 5.157

3.  Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity.

Authors:  Jemima Barrowman; Patricia A Wiley; Sarah E Hudon-Miller; Christine A Hrycyna; Susan Michaelis
Journal:  Hum Mol Genet       Date:  2012-06-19       Impact factor: 6.150

4.  New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update.

Authors:  Claire Laure Navarro; Vera Esteves-Vieira; Sébastien Courrier; Amandine Boyer; Thuy Duong Nguyen; Le Thi Thanh Huong; Peter Meinke; Winnie Schröder; Valérie Cormier-Daire; Yves Sznajer; David J Amor; Kristina Lagerstedt; Martine Biervliet; Peter C van den Akker; Pierre Cau; Patrice Roll; Nicolas Lévy; Catherine Badens; Manfred Wehnert; Annachiara De Sandre-Giovannoli
Journal:  Eur J Hum Genet       Date:  2013-10-30       Impact factor: 4.246

5.  Phenotypic heterogeneity of ZMPSTE24 deficiency.

Authors:  Thomas A Cassini; Amy K Robertson; Anna G Bican; Joy D Cogan; Vickie L Hannig; John H Newman; Rizwan Hamid; John A Phillips
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

6.  Hallermann-Streiff Syndrome: No Evidence for a Link to Laminopathies.

Authors:  F Kortüm; M Chyrek; S Fuchs; B Albrecht; G Gillessen-Kaesbach; U Mütze; E Seemanova; S Tinschert; D Wieczorek; G Rosenberger; K Kutsche
Journal:  Mol Syndromol       Date:  2011-11-12

7.  Cytoskeleton and nuclear lamina affection in recessive osteogenesis imperfecta: A functional proteomics perspective.

Authors:  Assunta Gagliardi; Roberta Besio; Chiara Carnemolla; Claudia Landi; Alessandro Armini; Mona Aglan; Ghada Otaify; Samia A Temtamy; Antonella Forlino; Luca Bini; Laura Bianchi
Journal:  J Proteomics       Date:  2017-08-09       Impact factor: 4.044

Review 8.  Lamins and bone disorders: current understanding and perspectives.

Authors:  Chiara Gargiuli; Elisa Schena; Elisabetta Mattioli; Marta Columbaro; Maria Rosaria D'Apice; Giuseppe Novelli; Tiziana Greggi; Giovanna Lattanzi
Journal:  Oncotarget       Date:  2018-04-27

9.  ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability.

Authors:  Eric D Spear; Erh-Ting Hsu; Laiyin Nie; Elisabeth P Carpenter; Christine A Hrycyna; Susan Michaelis
Journal:  Dis Model Mech       Date:  2018-07-13       Impact factor: 5.758

10.  Mandibuloacral dysplasia type B (MADB): a cohort of eight patients from Suriname with a homozygous founder mutation in ZMPSTE24 (FACE1), clinical diagnostic criteria and management guidelines.

Authors:  M M Hitzert; S N van der Crabben; G Baldewsingh; H K Ploos van Amstel; A van den Wijngaard; C M A van Ravenswaaij-Arts; C W R Zijlmans
Journal:  Orphanet J Rare Dis       Date:  2019-12-19       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.